Immunotech Laboratories, Inc. Stock
Stocks
IMMB
US45254F2039
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | -.--% |
|
-.--% | +100.00% |
| Market Cap | 6.06M 5.29M 4.86M 4.53M 8.6M 577M 8.73M 58.4M 22.7M 283M 22.73M 22.24M 977M | P/E 2008 * |
-
| P/E 2009 | -310x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25M 6.33M 5.82M 5.43M 10.29M 690M 10.45M 69.89M 27.17M 339M 27.2M 26.62M 1.17B | EV / Sales 2008 * |
-
| EV / Sales 2009 | - |
| Free-Float |
99.34% | Yield 2008 * |
-
| Yield 2009 | - |
| 6 months | +100.00% | ||
| Current year | +100.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.01 |
| 10 years | 0 | | 0.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
PSD | President | 59 | 21/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
CHM | Chairman | 59 | 01/07/2014 |
| Director/Board Member | 61 | 04/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +100.00% | -60.00% | 115K | |
| +0.68% | +5.92% | +77.86% | +139.22% | 59.1B | |
| +2.32% | +5.03% | +75.26% | +91.40% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -9.53% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +437.83% | 24.19B | |
| +4.74% | +13.68% | +43.36% | -4.67% | 19.69B | |
| -0.29% | +9.78% | +43.90% | -28.41% | 17.56B | |
| 0.00% | +20.78% | +186.15% | +361.42% | 16.22B | |
| +6.72% | +19.38% | +37.85% | - | 14.84B | |
| +3.50% | +1.97% | +21.02% | +191.95% | 14.04B | |
| Average | +2.58% | +7.71% | +58.82% | +124.36% | 24.55B | |
| Weighted average by Cap. | +2.46% | +6.47% | +58.32% | +136.98% |
| * | 1 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
4
- Stock Market
- Stocks
- IMMB Stock
Select your edition
All financial news and data tailored to specific country editions
